James Woody, MD, PhD, explains the benefits of treating Dupuytren’s disease with anti-tumor necrosis factor (TNF). Rheumatology Network interviewed James Woody, MD, PhD, to discuss the recent positive results of treating Dupuytren’s disease with anti-tumor necrosis factor (TNF). Woody is the CEO of 180 Life Sciences.  

Tony Clapsis, SVP and General Manager, CVS Clinical Trial Services, reflects on industry’s progress. May 20 is celebrated internationally as Clinical Trials Day, an effort led by the Association of Clinical Research Professionals (“ACRP”) to recognize and honor the dedication of clinical research professionals and the important role they play in conducting clinical research to […]

CVS Health has come a long way from its humble beginnings as a health and beauty products store in 1963. In recent years the retail pharmacy chain has begun to delve more and more deeply into the healthcare sector – by constantly expanding the basic healthcare services offered at their instore Minute Clinics, and by […]